Study on Artificial Bone Scaffolds with Control Release of Drugs by Low-Temperature Rapid Prototyping Technology

Abstract:

A kind of PLGA microspheres was prepared with bovine serum albumin (BSA) as the model drug and poly (lactide-co-glycolide) as the matrix. The polylactic acid/hydroxyapatite (PLA/HA) scaffold was manufactured through 3D printing technology. Then the PLGA microspheres were composited in the scaffold. It was also explored about the feasibility of skeletal scaffolds loaded with bone growth factor. The BSA loading PLGA microspheres were prepared by W/O/W method and the scaffolds were prepared by 3D-printing using PLA and HA as raw materials. The composite scaffold was fabricated by adsorbing the microspheres/ethanol suspension into scaffolds under negative pressure. The cell-adhesion ability, hydrophilicity, scaffold morphology, release properties and biocompatibility of the composite scaffold were characterized, respectively. The results show no burst release of BSA from the PLGA microspheres at beginning stage and sustained longer than 35 days. Drug-loading rate of microspheres was 0.64%. PLA/HA scaffold shows enhanced hydrophilicity as well as excellent cell compatibility and cell adhesion property. SEM images show PLGA microspheres were successfully absorbed in PLA/HA scaffold. MTT experiments of the composite scaffold show non cytotoxic and its cell relative proliferation rate is up to 88.37%. These studies show the feasibility of skeletal scaffolds loaded with bone growth factor. Through low-temperature rapid prototyping technology, the long-effective bioactive bone scaffold can be prepared and have a well application prospect.

• Periodical: Advanced Materials Research (Volume 647)
• Pages: 269-277
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.647.269
• Online since: January 2013
• Authors: Ming Bo Wang, Jian Xiong, Bin Chu, Rong Wei Tan, Wei Huang, Zhen Ding She
• Keywords: 3-D Printing, Bone Scaffold, Hydroxyapatite (HAP), PLGA Microspheres, Poly(lactic acid) (PLA)

References

[1] Yang, S., et al., The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Engineering, 2002. 8(1): pp.1-11.

DOI: 10.1089/107632702753503009

[2] Chua, C., W. Yeong, and K. Leong, Rapid prototyping in tissue engineering: a state-of-the-art report. Virtual Modelling and Rapid Manufacturing, (2005).

[3] Peltola, S.M., et al., A review of rapid prototyping techniques for tissue engineering purposes. Annals of medicine, 2008. 40(4): pp.268-280.

DOI: 10.1080/07853890701881788

[4] Yan, Y., et al., Rapid prototyping and manufacturing technology: principle, representative technics, applications, and development trends. Tsinghua Science & Technology, 2009. 14: pp.1-12.

DOI: 10.1016/s1007-0214(09)70059-8

[5] Yeong, W.Y., et al., Rapid prototyping in tissue engineering: challenges and potential. TRENDS in Biotechnology, 2004. 22(12): pp.643-652.

DOI: 10.1016/j.tibtech.2004.10.004

[6] Russias, J., et al., Fabrication and mechanical properties of PLA/HA composites: A study of in vitro degradation. Materials Science and Engineering: C, 2006. 26(8): pp.1289-1295.

DOI: 10.1016/j.msec.2005.08.004

[7] Kricheldorf, H.R., Syntheses and application of polylactides. Chemosphere, 2001. 43(1): pp.49-54.

DOI: 10.1016/s0045-6535(00)00323-4

[8] Higashi, S., et al., Polymer-hydroxyapatite composites for biodegradable bone fillers. Biomaterials, 1986. 7(3): pp.183-187.

DOI: 10.1016/0142-9612(86)90099-2

[9] Wang, M., et al., A dual microsphere based on PLGA and chitosan for delivering the oligopeptide derived from BMP-2. Polymer Degradation and Stability, 2011. 96(1): pp.107-113.

DOI: 10.1016/j.polymdegradstab.2010.10.010

[10] Lee, J.H., J.W. Park, and H.B. Lee, Cell adhesion and growth on polymer surfaces with hydroxyl groups prepared by water vapour plasma treatment. Biomaterials, 1991. 12(5): pp.443-448.

DOI: 10.1016/0142-9612(91)90140-6

[11] Rezwan, K., et al., Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials, 2006. 27(18): pp.3413-3431.

DOI: 10.1016/j.biomaterials.2006.01.039

[12] Landers, R., et al., Rapid prototyping of scaffolds derived from thermoreversible hydrogels and tailored for applications in tissue engineering. Biomaterials, 2002. 23(23): pp.4437-4447.

DOI: 10.1016/s0142-9612(02)00139-4

[13] Gumbiner, B.M., Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell, 1996. 84(3): p.345.

DOI: 10.1016/s0092-8674(00)81279-9

[14] Ghosh, D. and J. Sengupta, Molecular mechanism of embryo-endometrial adhesion in primates: a future task for implantation biologists. Molecular human reproduction, 1998. 4(8): pp.733-735.

DOI: 10.1093/molehr/4.8.733

[15] Hersel, U., C. Dahmen, and H. Kessler, RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials, 2003. 24(24): pp.4385-4415.

DOI: 10.1016/s0142-9612(03)00343-0

[16] Hallab, N., et al., Cell adhesion to biomaterials: correlations between surface charge, surface roughness, adsorbed protein, and cell morphology. Journal of long-term effects of medical implants, 1995. 5(3): p.209.

[17] Anselme, K., Osteoblast adhesion on biomaterials. Biomaterials, 2000. 21(7): pp.667-681.

DOI: 10.1016/s0142-9612(99)00242-2

[18] Zhang, R. and P.X. Ma, Poly (α-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. (1999).

[19] Burg, K.J.L., S. Porter, and J.F. Kellam, Biomaterial developments for bone tissue engineering. Biomaterials, 2000. 21(23): pp.2347-2359.

DOI: 10.1016/s0142-9612(00)00102-2